BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38868717)

  • 1. Establishing a novel inflammatory bowel disease prediction model based on gene markers identified from single nucleotide variants of the intestinal microbiota.
    Jiang S; Chen D; Ma C; Liu H; Huang S; Zhang J
    Imeta; 2022 Sep; 1(3):e40. PubMed ID: 38868717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a novel colorectal cancer predictive model based on unique gut microbial single nucleotide variant markers.
    Ma C; Chen K; Wang Y; Cen C; Zhai Q; Zhang J
    Gut Microbes; 2021; 13(1):1-6. PubMed ID: 33430705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in the Abundance and Co-occurrence of
    Lopez-Siles M; Enrich-Capó N; Aldeguer X; Sabat-Mir M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    Front Cell Infect Microbiol; 2018; 8():281. PubMed ID: 30245977
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
    Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
    World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome.
    Shen S; Huo D; Ma C; Jiang S; Zhang J
    Microbiol Spectr; 2021 Dec; 9(3):e0009021. PubMed ID: 34935421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
    Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
    J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review and meta-analysis of the role of Faecalibacterium prausnitzii alteration in inflammatory bowel disease.
    Zhao H; Xu H; Chen S; He J; Zhou Y; Nie Y
    J Gastroenterol Hepatol; 2021 Feb; 36(2):320-328. PubMed ID: 32815163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosa-associated Faecalibacterium prausnitzii phylotype richness is reduced in patients with inflammatory bowel disease.
    Lopez-Siles M; Martinez-Medina M; Abellà C; Busquets D; Sabat-Mir M; Duncan SH; Aldeguer X; Flint HJ; Garcia-Gil LJ
    Appl Environ Microbiol; 2015 Nov; 81(21):7582-92. PubMed ID: 26296733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of Akkermansia muciniphila in the inflammatory bowel disease patients with washed microbiota transplantation.
    Zhang T; Li P; Wu X; Lu G; Marcella C; Ji X; Ji G; Zhang F
    Appl Microbiol Biotechnol; 2020 Dec; 104(23):10203-10215. PubMed ID: 33064186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
    Ma Y; Zhang Y; Xiang J; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
    Front Cell Infect Microbiol; 2021; 11():599734. PubMed ID: 33738265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Crohn's disease and ulcerative colitis using the microbiome.
    Kang DY; Park JL; Yeo MK; Kang SB; Kim JM; Kim JS; Kim SY
    BMC Microbiol; 2023 Nov; 23(1):336. PubMed ID: 37951857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease - associations with disease phenotype, treatment, and outcome.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Jahnsen J; Ricanek P; Vatn S; Moen AEF; Tannæs TM; Lindstrøm JC; Söderholm JD; Halfvarson J; Gomollón F; Casén C; Karlsson MK; Kalla R; Adams AT; Satsangi J; Perminow G
    Clin Exp Gastroenterol; 2019; 12():37-49. PubMed ID: 30774408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
    Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
    World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method.
    Chen GB; Lee SH; Montgomery GW; Wray NR; Visscher PM; Gearry RB; Lawrance IC; Andrews JM; Bampton P; Mahy G; Bell S; Walsh A; Connor S; Sparrow M; Bowdler LM; Simms LA; Krishnaprasad K; ; Radford-Smith GL; Moser G
    BMC Med Genet; 2017 Aug; 18(1):94. PubMed ID: 28851283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease.
    Fujimoto T; Imaeda H; Takahashi K; Kasumi E; Bamba S; Fujiyama Y; Andoh A
    J Gastroenterol Hepatol; 2013 Apr; 28(4):613-9. PubMed ID: 23216550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.